Wells Fargo & Company G1 Therapeutics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 28,118 shares of GTHX stock, worth $201,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,118

Previous 31,065 9.49%

Holding current value

$201,043

Previous $134,000 52.24%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.2 - $4.98 $6,483 - $14,676	-2,947 Reduced 9.49%	28,118 $64,000
Q1 2024 May 10, 2024	BUY	$2.1 - $4.83 $17,864 - $41,088	8,507 Added 37.71%	31,065 $134,000
Q4 2023 Feb 09, 2024	BUY	$1.12 - $3.73 $1,475 - $4,912	1,317 Added 6.2%	22,558 $68,000
Q3 2023 Nov 13, 2023	SELL	$1.22 - $2.67 $11,458 - $25,076	-9,392 Reduced 30.66%	21,241 $30,000
Q2 2023 Aug 15, 2023	BUY	$2.46 - $3.14 $6,873 - $8,773	2,794 Added 10.04%	30,633 $76,000
Q1 2023 May 12, 2023	BUY	$2.57 - $8.16 $6,031 - $19,151	2,347 Added 9.21%	27,839 $74,000
Q4 2022 Feb 13, 2023	SELL	$5.19 - $13.5 $149,830 - $389,731	-28,869 Reduced 53.11%	25,492 $138,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $116,873 - $384,075	22,606 Added 71.19%	54,361 $680,000
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $54,067 - $113,889	-13,383 Reduced 29.65%	31,755 $157,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $93,852 - $136,085	-12,349 Reduced 21.48%	45,138 $343,000
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $497,006 - $791,004	-48,918 Reduced 45.97%	57,487 $587,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $126,414 - $215,846	9,606 Added 9.92%	106,405 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $354,256 - $476,444	18,102 Added 23.0%	96,799 $2.12 Million
Q1 2021 May 13, 2021	BUY	$17.58 - $32.59 $642,443 - $1.19 Million	36,544 Added 86.69%	78,697 $1.89 Million
Q4 2020 Feb 09, 2021	BUY	$10.99 - $20.4 $131,352 - $243,820	11,952 Added 39.57%	42,153 $758,000
Q3 2020 Nov 05, 2020	BUY	$11.55 - $23.75 $29,498 - $60,657	2,554 Added 9.24%	30,201 $349,000
Q2 2020 Aug 13, 2020	BUY	$9.57 - $24.37 $77,335 - $196,933	8,081 Added 41.3%	27,647 $671,000
Q1 2020 May 14, 2020	BUY	$9.07 - $26.32 $177,463 - $514,977	19,566 New	19,566 $216,000

Others Institutions Holding GTHX

# of Institutions

100

Shares Held

20.1M

Call Options Held

1.87M

Put Options Held

1.18M

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company G1 Therapeutics, Inc. Transaction History